电针刺激八髎穴治疗女性膀胱过度活动症的临床观察

被引:0
作者
李桂香
机构
[1] 福建中医学院
关键词
膀胱,异常活跃/针灸疗法; 电针; 穴,八髎; 问卷; 尿动力学;
D O I
暂无
年度学位
2008
学位类型
硕士
导师
摘要
目的 通过观察电针刺激八髎穴治疗前后膀胱过度活动症患者的排尿日记、病人生活质量影响问卷、尿垫试验、尿动力学检查等,探讨电针刺激八髎穴治疗女性膀胱过度活动症的临床疗效。 方法 本课题为随机对照试验。将临床收治的膀胱过度活动症妇女60例,最终入选57例(年龄18~85岁,平均年龄53.23±14.64岁)按就诊顺序随机分为电针刺激八髎穴治疗组A(n=21)、电针治疗组B(n=18)和针刺治疗组C(n=18)。电针刺激八髎穴治疗组:电针刺激八髎穴,留针20分钟;电针治疗组和针刺治疗组都取三阴交(双)、委阳(双)、膀胱俞(双)、中极、关元等穴位,针刺治疗组不接电针,都留针20分钟。记录治疗前和治疗后各组患者排尿日记(3天)、尿垫试验、尿动力学检查、尿失禁患者生活质量问卷等相关数据。通过比较治疗前后患者日平均排尿次数、次平均排尿量、尿急发生率、尿失禁发生率(漏尿发生率)、尿痛发生率、漏尿量、膀胱初感觉、初急、最大膀胱容量、排尿量、尿失禁患者生活质量评分和下尿路症状评分等的结果变化来评价其临床疗效。 结果 电针刺激八髎穴治疗组:尿失禁发生率好转55.91%;尿频好转24.94%;尿急发生率好转38.14%;平均每次排尿量增加33.51%;尿痛好转率:40.05%;膀胱初感增加率32.24%;初急增加率29.67%;最大膀胱容量增加率33.02%;下尿路症状评分好转70.01%;生活质量影响评分好转73.09%。 电针治疗组:尿失禁发生率好转56.71%;尿频好转19.36%;尿急发生率好转33.66%;平均每次排尿量增加21.25%;尿痛好转率:27.89%;膀胱初感增加率19.40%;初急增加率20.14%;最大膀胱容量增加率20.82%;下尿路症状评分好转57.84%;生活质量影响评分好转59.38%。 针刺治疗组:尿失禁发生率好转52.50%;尿频好转15.41%;尿急发生率好转33.56%;平均每次排尿量增加15.21%;尿痛好转率:24.31%;膀胱初感增加率19.71%;初急增加率17.36%;最大膀胱容量增加率14.37%;下尿路症状评分好转54.65%;生活质量影响评分好转53.73%。 结论 三个治疗组在接受了4周的治疗后,在尿频、尿急、漏尿发生率、尿痛、膀胱初感觉、初急、膀胱最大容量、排尿量、生活质量影响评分、下尿路症状评分等方面与治疗前相比均有显著差异(P<0.01);电针刺激八髎穴治疗组改善膀胱过度活动症的临床症状和患者的生活质量方面明显优于另外两组。
引用
收藏
页数:59
共 37 条
[1]
Intravesical glucidic capsaicin versus glucidic solvent in neurogenic detrusor overactivity:: A double blind controlled randomized study [J].
de Seze, Marianne ;
Gallien, Philippe ;
Denys, Pierre ;
Labat, Jean-Jacques ;
Serment, Gerard ;
Grise, Philippe ;
Salle, Jean-Yves ;
Blazejewski, Sylvie ;
Hazane, Cecile ;
Moore, Nicholas ;
Joseph, Pierre-Alain .
NEUROUROLOGY AND URODYNAMICS, 2006, 25 (07) :752-757
[2]
Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin [J].
Cardozo, Linda ;
Castro-Diaz, David ;
Gittelman, Marc ;
Ridder, Arwin ;
Huang, Moses .
INTERNATIONAL UROGYNECOLOGY JOURNAL, 2006, 17 (05) :512-519
[3]
Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin [J].
Cardozo, Linda ;
Castro-Diaz, David ;
Gittelman, Marc ;
Ridder, Arwin ;
Huang, Moses .
INTERNATIONAL UROGYNECOLOGY JOURNAL, 2006, 17 (05) :512-519
[4]
Trospium chloride: an anticholinergic quaternary ammonium compound for the treatment of overactive bladder [J].
Zinner, NR .
EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (08) :1409-1420
[5]
Prevalence of the overactive bladder syndrome by applying the international continence society definition [J].
Temml, C ;
Heidler, S ;
Ponholzer, A ;
Madersbacher, S .
EUROPEAN UROLOGY, 2005, 48 (04) :622-627
[6]
Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: A prospective study [J].
Comiter, CV .
JOURNAL OF UROLOGY, 2003, 169 (04) :1369-1373
[7]
The effect of behavioral therapy on urinary incontinence: a randomized controlled trial.[J].Leslee L Subak;Charles P Quesenberry;Samuel F Posner;Eugene Cattolica;Krikor Soghikian.Obstetrics & Gynecology.2002, 1
[8]
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: Results of the OBJECT study [J].
Appell, RA ;
Sand, P ;
Dmochowski, R ;
Anderson, R ;
Zinner, N ;
Lama, D ;
Roach, M ;
Miklos, J ;
Saltzstein, D ;
Boone, T ;
Staskin, DR ;
Albrecht, D .
MAYO CLINIC PROCEEDINGS, 2001, 76 (04) :358-363
[9]
Anorectal and bladder function after sacrifice of the sacral nerves [J].
Nakai, S ;
Yoshizawa, H ;
Kobayashi, S ;
Maeda, K ;
Okumura, Y .
SPINE, 2000, 25 (17) :2234-2239
[10]
Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence; urgency-frequency; and retention.[J].Steven W. Siegel;Francesco Catanzaro;Hero E. Dijkema;Mostafa M. Elhilali;Clare J. Fowler;Jerzy B. Gajewski;Magdy M. Hassouna;Rudi A. Janknegt;Udo Jonas;Philip E.V. van Kerrebroeck;A.A.B. Lycklama a Nijeholt;Kimberly A. Oleson;Richard A. Schmidt.Urology.2000, 6